Apyx Medical Corporation (APYX) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Apyx Medical Corporation (APYX) following the 2026 Q2 hedge fund 13F filings?

As of today, APYX has moved +2.6% since the 2026 Q2 13F filing date (August 14, 2026), compared to +4.3% for the XLV sector ETF — an outperformance of -1.7%. Since the quarter end (June 30, 2026), APYX gained -30.7% vs +10.0% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Apyx Medical Corporation (APYX)

67 + Investors. Track Smart Money conviction in APYX. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — APYX

Based on 66 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added APYX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

66 hedge funds hold APYX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +50% more funds vs a year ago

fund count last 6Q

+22 new funds entered over the past year (+50% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 3 quarters from the low — a sharp move.

🟢

More buyers than sellers — 61% buying

39 buying25 selling

Last quarter: 39 funds were net buyers (16 opened a brand new position + 23 added to an existing one). Only 25 were sellers (17 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~16 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 4 → 13 → 18 → 16. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

47% of holders stayed for 2+ years

■ 47% conviction (2yr+) ■ 23% medium ■ 30% new

31 out of 66 hedge funds have held APYX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

🚀

Acceleration phase — new buyers rushing in

5 → 4 → 13 → 18 → 16 new funds/Q

New funds entering each quarter: 4 → 13 → 18 → 16. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Veteran-anchored — 66% veterans vs 27% newcomers

■ 66% veterans ■ 7% 1-2yr ■ 27% new

Entry-cohort mix of 67 holders: 44 (66%) are 2+ year veterans, 5 entered 1–2 years ago, and 18 (27%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

📋

Smaller funds dominant — 9% AUM from top-100

9% from top-100 AUM funds

18 of 66 holders rank in the top 100 by AUM, but together hold only 9% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.6

out of 10

Moderate Exit Risk

Exit risk score 4.6/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	67	66	1.52%
13F Shares	21M	21M	2.34%
Total Value	$96M	$77M	24.73%
New Positions	11	16	-5
Increased Positions	23	22	+1
Closed Positions	10	8	+2
Reduced Positions	22	16	+6
Total Calls	1	1	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

1.52%

13F Shares

21M

2.34%

Total Value

$96M

$77M

24.73%

New Positions

-5

Increased Positions

Closed Positions

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

67 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in APYX. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 APYX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Archon Capital Management LLC	4.82%	2,644,717	$11.9M
2	Silverberg Bernstein Capital Management LLC	1.79%	1,039,641	$4.7M
3	Taylor Frigon Capital Management LLC	0.87%	413,602	$1.9M
4	Essex Investment Management Co LLC	0.67%	1,136,630	$5.1M
5	Nantahala Capital Management, LLC	0.49%	3,270,248	$14.7M
6	AIGH Capital Management LLC	0.32%	1,128,343	$5.1M
7	Huntleigh Advisors, Inc.	0.17%	263,231	$1.2M
8	Legato Capital Management LLC	0.14%	382,762	$1.7M
9	Perkins Capital Management Inc	0.14%	42,000	$189K
10	Royce & Associates LP	0.12%	3,274,064	$14.7M
11	Dauntless Investment Group, LLC	0.11%	30,249	$136K
12	Z3 Capital Partners, LLC	0.09%	91,109	$409K
13	Kanen Wealth Management LLC	0.08%	74,900	$336K
14	RPg Family Wealth Advisory, LLC	0.07%	76,250	$342K
15	Informed Momentum Co LLC	0.07%	170,470	$765K
16	Horizon Kinetics Asset Management LLC	0.03%	585,000	$2.6M
17	Scholtz & Company, LLC	0.02%	10,000	$45K
18	Hillsdale Investment Management Inc.	0.02%	182,600	$820K
19	Kingsview Wealth Management, LLC	0.01%	214,288	$962K
20	Axq Capital, LP	0.01%	17,308	$78K
21	Bridgeway Capital Management, LLC	0.00%	61,601	$277K
22	Nwam LLC	0.00%	17,239	$77K
23	Caption Management, LLC	0.00%	183,003	$822K
24	Commonwealth Equity Services, LLC	0.00%	649,061	$2.9M
25	Renaissance Technologies LLC	0.00%	554,278	$2.5M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Apyx Medical Corporation (APYX)

What does the Smart Money Trend signal show for APYX?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added APYX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for APYX?

More buyers than sellers — 61% buying: Last quarter: 39 funds were net buyers (16 opened a brand new position + 23 added to an existing one). Only 25 were sellers (17 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for APYX holders?

Smaller funds dominant — 9% AUM from top-100: 18 of 66 holders rank in the top 100 by AUM, but together hold only 9% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held APYX?

47% of holders stayed for 2+ years: 31 out of 66 hedge funds have held APYX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Apyx Medical Corporation (APYX) following the 2026 Q2 hedge fund 13F filings?

As of today, APYX has moved +2.6% since the 2026 Q2 13F filing date (August 14, 2026), compared to +4.3% for the XLV sector ETF — an outperformance of -1.7%. Since the quarter end (June 30, 2026), APYX has gained -30.7% vs +10.0% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Apyx Medical Corporation (APYX)

Smart Money Signals — APYX

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +50% more funds vs a year ago

More buyers than sellers — 61% buying

Steady new buyers — ~16 new funds per quarter

47% of holders stayed for 2+ years

Acceleration phase — new buyers rushing in

Veteran-anchored — 66% veterans vs 27% newcomers

Smaller funds dominant — 9% AUM from top-100

Institutional Sentiment Summary — APYX

Hedge Fund Ownership: APYX

Market Analysis: APYX

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: APYX

Is It Too Late to Buy Apyx Medical Corporation (APYX) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: APYX

Statistics: APYX

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Apyx Medical Corporation (APYX)

Welcome to 13Foresight!